Search Within

Qing-Bai She

  1. "Genitourinary Oncology Service"
Formats
  1. Meeting Abstract (13)
  2. Journal Article (7)
Groups
  1. Department of Medicine (20)
  2. GSK Faculty (20)
  3. Genitourinary Oncology Service (20)
  4. Human Oncology and Pathogenesis Program (20)
  5. Solid Tumor Oncology Division (20)
  6. Sloan Kettering Institute Faculty (19)

More Groups

People
  1. David Solit (20)
  2. Neal Rosen (18)
  3. Qing Ye (10)
  4. Kathryn O'reilly (5)
  5. Manickam Janakiraman (4)
  6. Mark Moasser (4)

More People

Years
  1. 2012 (2)
  2. 2010 (4)
  3. 2008 (1)
  4. 2007 (1)
  5. 2006 (4)
  6. 2005 (4)

More Years

Publications
  1. Cancer Research (11)
  2. Clinical Cancer Research (3)
  3. Cancer Cell (2)
  4. Cancer Discovery (1)
  5. EJC Supplements (1)
  6. Oncogene (1)

More Publications

Publishers
  1. American Association for Cancer Research (16)
  2. Cell Press (2)
  3. Nature Publishing Group (1)
  4. Pergamon-Elsevier Science Ltd (1)

Results (20)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic complexity and AKT dependence in serous ovarian cancer
    Journal Article

    Hanrahan, A. J.; Schultz, N.; Westfal, M. L.; Sakr, R. A.; Giri, D. D.; Scarperi, S.; Janakiraman, M.; Olvera, N.; Stevens, E. V.; She, Q. B.; more...
    Cancer Discovery (2012)

    Fulltext@MSK | Save
  • Concurrent loss of the PTEN and RB1 tumor suppressors attenuates RAF dependence in melanomas harboring V600E BRAF
    Journal Article

    Xing, F.; Persaud, Y.; Pratilas, C. A.; Taylor, B. S.; Janakiraman, M.; She, Q. B.; Gallardo, H.; Liu, C.; Merghoub, T.; Hefter, B.; more...
    Oncogene (2012)

    Fulltext@MSK | Save
  • Concurrent loss of PTEN and RB is sufficient to confer BRAF independence in melanomas harboring V600E BRAF mutations
    Meeting Abstract

    Xing, F.; Persaud, Y.; Pratilas, C.; Janakiraman, M.; She, Q. B.; Liu, C.; Dolgalev, I.; Heguy, A.; Wolchok, J.; Cobrinik, D.; more...
    Cancer Research (2010)

    Fulltext@MSK | Save
  • Genetic determinants of AKT-dependence in epithelial ovarian cancer
    Meeting Abstract

    Hanrahan, A. J.; Scarperi, S.; Sakr, R. A.; Westfal, M. L.; Godsell, J.; Janakiraman, M.; Levine, D. A.; She, Q. B.; Rosen, N.; Solit, D. B.
    Cancer Research (2010)

    Fulltext@MSK | Save
  • 4E-BP1 is a key effector of the oncogenic activation of the AKT and ERK signaling pathways that integrates their function in tumors
    Journal Article

    She, Q. B.; Halilovic, E.; Ye, Q.; Zhen, W.; Shirasawa, S.; Sasazuki, T.; Solit, D. B.; Rosen, N.
    Cancer Cell (2010)

    Fulltext@MSK | Save
  • PIK3CA mutation uncouples tumor growth and cyclin D1 regulation from MEK/ERK and mutant KRAS signaling
    Journal Article

    Halilovic, E.; She, Q. B.; Ye, Q.; Pagliarini, R.; Sellers, W. R.; Solit, D. B.; Rosen, N.
    Cancer Research (2010)

    Fulltext@MSK | Save
  • Coexistent PI3K mutation in human tumors is associated with decreased dependency on mutant KRAS and MEK/ERK signaling for transformation
    Meeting Abstract

    Halilovic, E.; She, Q.; Ye, Q.; Solit, D. B.; Rosen, N.
    Cancer Research (2008)

    Fulltext@MSK | Save
  • The PI3K/AKT and MAPK signaling cooperate to mediate translational initiation and cell survival in human tumors
    Meeting Abstract

    She, Q. B.; Ye, Q.; Zhen, W.; Solit, D.; Rosen, N.
    Cancer Research (2007)

    Fulltext@MSK | Save
  • Genetic and pharmacological inhibition of P13 kinase signaling in vivo sensitizes tumors to EGFR inhibitors and to taxol
    Meeting Abstract

    She, Q. B.; Ye, Q.; She, Y.; Solit, D. B.; Rosen, N.
    Cancer Research (2006)

    Fulltext@MSK | Save
  • IGF-1 rescues rapamycin-induced cell growth inhibition
    Meeting Abstract

    O'reilly, K. E.; She, Q. B.; Solit, D. B.; Rosen, N.
    Cancer Research (2006)

    Fulltext@MSK | Save